1. Home
  2. CDXS vs CIO Comparison

CDXS vs CIO Comparison

Compare CDXS & CIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • CIO
  • Stock Information
  • Founded
  • CDXS 2002
  • CIO 2013
  • Country
  • CDXS United States
  • CIO Canada
  • Employees
  • CDXS N/A
  • CIO N/A
  • Industry
  • CDXS Major Chemicals
  • CIO Real Estate Investment Trusts
  • Sector
  • CDXS Industrials
  • CIO Real Estate
  • Exchange
  • CDXS Nasdaq
  • CIO Nasdaq
  • Market Cap
  • CDXS 230.3M
  • CIO 202.0M
  • IPO Year
  • CDXS 2010
  • CIO 2014
  • Fundamental
  • Price
  • CDXS $2.81
  • CIO $5.22
  • Analyst Decision
  • CDXS Buy
  • CIO
  • Analyst Count
  • CDXS 2
  • CIO 0
  • Target Price
  • CDXS $11.00
  • CIO N/A
  • AVG Volume (30 Days)
  • CDXS 1.1M
  • CIO 182.5K
  • Earning Date
  • CDXS 05-01-2025
  • CIO 05-02-2025
  • Dividend Yield
  • CDXS N/A
  • CIO 7.68%
  • EPS Growth
  • CDXS N/A
  • CIO N/A
  • EPS
  • CDXS N/A
  • CIO N/A
  • Revenue
  • CDXS $59,345,000.00
  • CIO $171,126,000.00
  • Revenue This Year
  • CDXS $14.56
  • CIO $0.98
  • Revenue Next Year
  • CDXS $21.41
  • CIO $3.56
  • P/E Ratio
  • CDXS N/A
  • CIO N/A
  • Revenue Growth
  • CDXS N/A
  • CIO N/A
  • 52 Week Low
  • CDXS $2.43
  • CIO $4.29
  • 52 Week High
  • CDXS $6.08
  • CIO $6.50
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 42.35
  • CIO 55.54
  • Support Level
  • CDXS $2.43
  • CIO $5.06
  • Resistance Level
  • CDXS $3.04
  • CIO $5.35
  • Average True Range (ATR)
  • CDXS 0.22
  • CIO 0.19
  • MACD
  • CDXS 0.08
  • CIO 0.03
  • Stochastic Oscillator
  • CDXS 51.35
  • CIO 81.62

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

About CIO City Office REIT Inc.

City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. The company owns office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.

Share on Social Networks: